Gopaluni, Seerapani
Smith, Rona
Goymer, Donna
Cahill, Hugh
Broadhurst, Elizabeth
Wallin, Elizabeth
McClure, Mark
Chaudhry, Afzal
Jayne, David
Article History
Received: 22 December 2021
Accepted: 6 March 2022
First Online: 1 April 2022
Declarations
:
: This study was approved by the NRES Committee East of England – Cambridge East. REC reference number: 10/H0304/64. All patients gave informed and written consent to participate in the trial have read and understood the patient information sheet.
: Not applicable
: DJ has received research grants from Chemocentryx, GSK, Roche/Genentech and Sanofi-Genzyme and consultancy fees from Astra-Zeneca, Boehringer-Ingelheim, Chemocentryx, Chugai, GSK, Infla-RX, Insmed and Takeda. RS has received lecture fess from Roche and consultancy fees from GSK and Nordic Pharma. SG, DG, HC, EB, EW, MM, AC none.